OXB — Oxford BioMedica Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Oxford BioMedica, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	16.2	46.7	109	141	104
Net Total Accounts Receivable
Net Total Receivables	33.6	51.4	42.1	57.6	20.4
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	56.9	108	164	216	141
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	61.9	72.3	69.7	134	75.7
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	123	184	237	460	252
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	28.9	52.5	33.3	59.7	44.3
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	47.3	71.2	49.9	256	178
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	75.6	113	187	205	74
Total Liabilities & Shareholders' Equity	123	184	237	460	252
Total Common Shares Outstanding